CareLit Fachartikel

Activation of the SKP2 protooncogene is a common effector pathway in hepatocarcinogenesis and contributes to malignant transformation of the liver

DF Calvisi, X Chen, C Ho, S Ladu, S Mattu, G Destefanis, S Delogu, F Dombrowski, M Evert · Zeitschrift für Gastroenterologie · 2011 · Heft 01

Dokument
1169814
CareLit-ID
Jahr
2011
Publikation
PDF
nein
Metadaten
DOI
ja
zitierfähig

Bibliografische Angaben

Zeitschrift
Zeitschrift für Gastroenterologie
Autor:innen
DF Calvisi, X Chen, C Ho, S Ladu, S Mattu, G Destefanis, S Delogu, F Dombrowski, M Evert
Ausgabe
Heft 01 / 2011
Seiten
–
Erschienen: 2011-01-13 00:00:00
ISSN
0044-2771

Zusammenfassung

We have recently shown that upregulation of SKP2 protooncogene is associated with the development and progression of human hepatocellular carcinoma (HCC). In the present study, we further investigated the functional role of SKP2 by using in vitro and in vivo approaches. Forced overexpression of a number of known liver oncogenes, including AKT, E2F1, N-Ras, ERK2, STAT5b, and mutated beta-catenin in human HCC cell lines led to increased proliferation, which was associated with the rise in the levels and activation of SKP2 (as assessed by SKP2-mediated degradation of p27, p57, and p130 target genes). Although the p…

Schlagworte

AKT E2F1 ERK2 FOXM1 HCC Hepatocarcinogenesis N-Ras SKP2 Stat5b beta-catenin hydrodynamic gene delivery p130 p27 p57 beta Catenin After